✦ LIBER ✦

Applications of Cell-Penetrating Peptides for Tumor Targeting and Future Cancer Therapies

✍ Scribed by Regberg, Jakob; Srimanee, Artita; Langel, Ülo

Book ID: 119941207
Publisher: MDPI AG
Year: 2012
Tongue: English
Weight: 256 KB
Volume: 5
Category: Article
ISSN: 1424-8247
DOI: 10.3390/ph5090991

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current status and future applications o

Current status and future applications of cellular therapies for cancer

✍ Copier, John; Bodman-Smith, Mark; Dalgleish, Angus 📂 Article 📅 2011 🏛 Future Medicine 🌐 English ⚖ 473 KB

Harnessing the power of cell-penetrating

Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents

✍ Sarah R. MacEwan; Ashutosh Chilkoti 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 570 KB

Recent advances in the use of cell-penet

Recent advances in the use of cell-penetrating peptides for medical and biological applications

✍ Sonali B. Fonseca; Mark P. Pereira; Shana O. Kelley 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 656 KB

Targeted therapies for advanced non-smal

Targeted therapies for advanced non-small-cell lung cancer: Current status and future implications

✍ Ana Custodio; Míriam Méndez; Mariano Provencio 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 327 KB

Clinical trials and future potential of

Clinical trials and future potential of targeted therapy for ovarian cancer

✍ Itamochi, Hiroaki; Kigawa, Junzo 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 274 KB

Clinical trials and future potential of

Clinical trials and future potential of targeted therapy for ovarian cancer

✍ Itamochi, Hiroaki; Kigawa, Junzo 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 274 KB

Ovarian cancer is the leading cause of death in women with gynecological cancer. Most patients are diagnosed at an advanced stage with a poor prognosis. Currently, surgical tumor debulking followed by chemotherapy based on platinum and taxane is the standard treatment for advanced disease. However,